| 2026-05-05 09:21 |
8-K |
["2.01", "3.01", "5.01", "5.03"] |
tender offer |
1.00
|
Merck completed tender offer for Terns at $53/share with 86.36% acceptance; merger consummated May 5, 2026. |
SEC · detail |
| 2026-05-05 08:52 |
SC TO-T |
|
tender offer |
1.00
|
Merck completed acquisition of Terns Pharmaceuticals at $53/share; tender offer expired with 86.36% acceptance; merger consummated. |
SEC · detail |
| 2026-04-27 08:10 |
8-K |
["7.01", "8.01"] |
other |
0.05
|
FDA Breakthrough Therapy Designation for TERN-701; no M&A signals present. |
SEC · detail |
| 2026-04-24 07:30 |
SC TO-T |
|
tender offer |
0.99
|
Merck's amended tender offer for Terns Pharmaceuticals at $53/share; HSA waiting period expired April 23, 2026. |
SEC · detail |